IgA Immunostain, Technical Component Only
Use
The IgA Immunostain test assists in the classification of lymphomas and multiple myeloma. It aids in diagnosing and classifying small B-cell malignant lymphomas and multiple myeloma by targeting immunoglobulin heavy chains, specifically IgA, which is a major immunoglobulin found at mucosal surfaces.
Special Instructions
Not provided.
Limitations
The test does not include pathologist interpretation, only technical performance of the stain. Glass slides may be affected by environmental factors which can alter slide staining, and cut paraffin sections may lose antigen reactivity over time; best practices should minimize storage and exposure to heat and humidity.
FDA ApprovedNew York Approved
Methodology
Immunoassay (IHC)
Biomarkers
IgA
Protein
LOINC Codes
- Order only;no result
- Bill only; no result
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
Not provided
Container
Immunostain Technical Only Envelope
Causes for Rejection
Wet/frozen tissue, nonformalin fixed tissue, nonparaffin embedded tissue, noncharged slides, ProbeOn slides, Snowcoat slides.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Ambient (preferred) |
| Refrigerated | Refrigerated |